New pill could bring back skin color for vitiligo patients
NCT ID NCT06790862
First seen Jan 19, 2026 · Last updated May 22, 2026 · Updated 17 times
Summary
This study tests an experimental drug called SHR0302Base in 155 adults with stable nonsegmental vitiligo, a condition where white patches appear on the skin. The goal is to see if the drug can safely restore at least 50% of color to the face and neck over several months. Participants are randomly assigned to receive either the drug or a placebo, and neither they nor their doctors will know which they get.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VITILIGO are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Dermatology Hospital affiliated to Shandong First Medical University
Jinan, Shandong, 250022, China
Conditions
Explore the condition pages connected to this study.